Ropinirole
Total Payments
$161,457
Transactions
37
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $10,616 | 5 | 0 |
| 2019 | $3,085 | 8 | 0 |
| 2018 | $147,755 | 24 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $161,457 | 37 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Ropinirole Implants in Parkinson's Patients | Titan Pharmaceuticals, Inc. | $161,457 | 0 |
Top Doctors Receiving Payments for Ropinirole
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Boston, MA | $161,457 | 37 |
Ad
Manufacturing Companies
- Titan Pharmaceuticals, Inc. $161,457
Product Information
- Type Drug
- Total Payments $161,457
- Total Doctors 0
- Transactions 37
About Ropinirole
Ropinirole is a drug associated with $161,457 in payments to 0 healthcare providers, recorded across 37 transactions in the CMS Open Payments database. The primary manufacturer is Titan Pharmaceuticals, Inc..
Payment data is available from 2018 to 2020. In 2020, $10,616 was paid across 5 transactions to 0 doctors.
The most common payment nature for Ropinirole is "Unspecified" ($161,457, 100.0% of total).
Ropinirole is associated with 1 research study, including "Ropinirole Implants in Parkinson's Patients" ($161,457).